DYRK1A Signaling in the Brain: Molecular Mechanisms and Neurotransmitter Regulation

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A) is a dosage-sensitive gene crucial for central nervous system development.
• Dysregulation of DYRK1A is implicated in neurodevelopmental disorders such as Down Syndrome, Autism Spectrum Disorder, and Intellectual Developmental Disorder.

Purpose of the Study:

• To review the role of DYRK1A dosage in shaping neurodevelopment, neurotransmitter regulation, and disease phenotypes.
• To examine evidence from various models to understand DYRK1A's impact on brain development.

Main Methods:

• Synthesized molecular, cellular, and systems-level evidence from 2015-2025.
• Included studies from rodent DYRK1A mutant models, human iPSC-derived neural progenitors, and human transcriptomic datasets.
• Assessed studies for mechanistic rigor, species applicability, and translational potential.

Main Results:

• DYRK1A coordinates neural progenitor proliferation, differentiation, and cell cycle regulation.
• DYRK1A influences chromatin remodeling, glutamatergic synaptic transmission, and glial differentiation/myelination.
• DYRK1A overexpression in Down Syndrome disrupts neurogenesis and synaptic connectivity; haploinsufficiency leads to microcephaly and intellectual disability.

Conclusions:

• DYRK1A is a dosage-sensitive regulator of neurogenesis, chromatin remodeling, synaptic transmission, and glial maturation.
• Mechanistic divergence and inter-individual variability in models complicate translational research.
• Therapeutic strategies require precise titration, emphasizing the need for personalized medicine approaches for dosage-sensitive genes.